Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
---|---|---|---|---|---|---|
A.H. Robins Company | Aspirin, Methocarbamol | Robaxisal |  | 1982-01-01 |  |  |
AAIPharma | Azathioprine | Azasan |  | 1999-06-07 |  |  |
Aspirin, Propoxyphene napsylate | Darvon-n W/ Asa |  | 1982-01-01 |  |  | |
Abbott Biotherapeutics | Adalimumab | Trudexa |  | 2003-09-01 |  |  |
Aspirin, Hydrocodone | Vicoprin |  | 1983-09-14 |  |  | |
Ibuprofen | Ibu |  | 1989-12-18 |  |  | |
Ibuprofen | Ibuprofen |  | 1985-06-14 |  |  | |
AbbVie | Adalimumab | Humira |  | 2002-12-31 | $10,615 M | Q4/23-Q3/24 |
Upadacitinib | Rinvoq | 2031-01-15 | 2019-08-16 | $5,392 M | Q4/23-Q3/24 | |
Ibuprofen, Hydrocodone | Vicoprofen |  | 1997-09-23 |  |  | |
Cyclosporine | Cyclosporine |  | 2000-03-03 |  |  | |
Cyclosporine | Gengraf |  | 2000-05-12 |  |  | |
Cyclosporine | Restasis Multidose | 2024-08-27 | 2002-12-23 |  |  | |
Able Laboratories | Naproxen | Naproxen |  | 2003-08-22 |  |  |
Accord Healthcare | Methotrexate | Methotrexate |  | 2007-04-30 |  |  |
Hydroxychloroquine | Hydroxychloroquine |  | 2020-04-07 |  |  | |
ACIC Pharmaceuticals | Celecoxib | Celecoxib |  | 2020-12-09 |  |  |
Aet Pharma | Leflunomide | Leflunomide |  | 2021-05-10 |  |  |
Ajanta Pharma | Tofacitinib | Tofacitinib |  | 2021-06-01 |  |  |
Naproxen, Esomeprazole strontium | Naproxen Esomeprazole Magnesium |  | 2022-10-06 |  |  | |
Alembic Pharmaceuticals | Methotrexate | Methotrexate |  | 2024-06-03 |  |  |
Celecoxib | Celecoxib |  | 2015-08-21 |  |  | |
Diclofenac | Diclofenac |  | 2022-07-27 |  |  | |
Leflunomide | Leflunomide |  | 2011-11-21 |  |  |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
---|---|---|---|---|---|